SUBSTRATE-SPECIFICITY AND INHIBITION OF UDP-GLCNAC-GLCNAC-BETA-1-2MAN-ALPHA-1-6R BETA-1-6-N-ACETYLGLUCOSAMINYLTRANSFERASE-V USING SYNTHETICSUBSTRATE-ANALOGS
I. Brockhausen et al., SUBSTRATE-SPECIFICITY AND INHIBITION OF UDP-GLCNAC-GLCNAC-BETA-1-2MAN-ALPHA-1-6R BETA-1-6-N-ACETYLGLUCOSAMINYLTRANSFERASE-V USING SYNTHETICSUBSTRATE-ANALOGS, Glycoconjugate journal, 12(3), 1995, pp. 371-379
UDP-GlcNAc:GlcNAc beta 1-2Man alpha 1-6R (GlcNAc to Man) beta 1,6-N-ac
etylglucosaminyltransferase V (GlcNAc-T V) adds a GlcNAc beta 1-6 bran
ch to bi- and triantennary N-glycans. An increase in this activity has
been associated with cellular transformation, metastasis and differen
tiation. We have used synthetic substrate analogues to study the subst
rate specificity and inhibition of the partially purified enzyme from
hamster kidney and of extracts from hen oviduct membranes and acute my
eloid leukaemia leukocytes. All compounds with the minimum structure G
lcNAc beta 1-2Man alpha 1 -6Glc/Man beta- were good substrates for Glc
NAc-T V. The presence of structural elements other than the minimum tr
isaccharide structure affected GlcNAc-T V activity without being an ab
solute requirement for activity. Substrates with a biantennary structu
re were preferred over linear fragments of biantennary structures. Kin
etic analysis showed that the 3-hydroxyl of the Man alpha 1-3 residue
and the 4-hydroxyl of the Man beta- residue of the Man alpha 1-6(Man a
lpha 1-3)Man beta-R N-glycan core are not essential for catalysis but
influence substrate binding. GlcNAc beta 1-2(4,6-di-O-methyl-)Man alph
a 1- 6Glc beta-pnp was found to be an inhibitor of GlcNAc-T V from ham
ster kidney, hen oviduct microsomes and acute and chronic myeloid leuk
aemia leukocytes.